866-997-4948(US-Canada Toll Free)

Global Ophthalmology Drugs Market Size, Status and Forecast 2019-2025

Published By :

QYResearch

Published Date : Jan 2019

Category :

Healthcare

No. of Pages : 98 Pages

Ophthalmology is a broad therapy area that consists of almost 100 disorders associated with the eyes and visual system, including such diseases as glaucoma, age-related macular degeneration (AMD), diabetic macular edema (DME), diabetic retinopathy (DR) and dry eye syndrome (DES). Many of these disorders are progressive, and if left untreated can lead to severe visual impairment or even blindness.
Of the five key indications within the therapy area - glaucoma, AMD, DME, DR and DES - glaucoma and AMD have the most active product pipelines.
In 2018, the global Ophthalmology Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Ophthalmology Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Ophthalmology Drugs development in United States, Europe and China.

The key players covered in this study
Novartis
Regeneron
Roche
Bayer
Allergan
Shire
Mallinckrodt
Santen Pharmaceutical
Aerie

Market segment by Type, the product can be split into
Lucentis (Ranibizumab)
Eylea (Aflibercept)
Avastin (Bevacizumab)
Restasis (Cyclosporine)
Alphagan (Brimonidine Tartrate)
Lumigan (Bimatoprost)
Xalatan (Latanoprost)
Conclusion

Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Online Sales

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Ophthalmology Drugs status, future forecast, growth opportunity, key market and key players.
To present the Ophthalmology Drugs development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Ophthalmology Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Ophthalmology Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 Lucentis (Ranibizumab)
1.4.3 Eylea (Aflibercept)
1.4.4 Avastin (Bevacizumab)
1.4.5 Restasis (Cyclosporine)
1.4.6 Alphagan (Brimonidine Tartrate)
1.4.7 Lumigan (Bimatoprost)
1.4.8 Xalatan (Latanoprost)
1.4.9 Conclusion
1.5 Market by Application
1.5.1 Global Ophthalmology Drugs Market Share by Application (2014-2025)
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Drug Stores
1.5.5 Online Sales
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Ophthalmology Drugs Market Size
2.2 Ophthalmology Drugs Growth Trends by Regions
2.2.1 Ophthalmology Drugs Market Size by Regions (2014-2025)
2.2.2 Ophthalmology Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Ophthalmology Drugs Market Size by Manufacturers
3.1.1 Global Ophthalmology Drugs Revenue by Manufacturers (2014-2018)
3.1.2 Global Ophthalmology Drugs Revenue Market Share by Manufacturers (2014-2018)
3.1.3 Global Ophthalmology Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Ophthalmology Drugs Key Players Head office and Area Served
3.3 Key Players Ophthalmology Drugs Product/Solution/Service
3.4 Date of Enter into Ophthalmology Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Ophthalmology Drugs Market Size by Type (2014-2019)
4.2 Global Ophthalmology Drugs Market Size by Application (2014-2019)

5 United States
5.1 United States Ophthalmology Drugs Market Size (2014-2019)
5.2 Ophthalmology Drugs Key Players in United States
5.3 United States Ophthalmology Drugs Market Size by Type
5.4 United States Ophthalmology Drugs Market Size by Application

6 Europe
6.1 Europe Ophthalmology Drugs Market Size (2014-2019)
6.2 Ophthalmology Drugs Key Players in Europe
6.3 Europe Ophthalmology Drugs Market Size by Type
6.4 Europe Ophthalmology Drugs Market Size by Application

7 China
7.1 China Ophthalmology Drugs Market Size (2014-2019)
7.2 Ophthalmology Drugs Key Players in China
7.3 China Ophthalmology Drugs Market Size by Type
7.4 China Ophthalmology Drugs Market Size by Application

8 Japan
8.1 Japan Ophthalmology Drugs Market Size (2014-2019)
8.2 Ophthalmology Drugs Key Players in Japan
8.3 Japan Ophthalmology Drugs Market Size by Type
8.4 Japan Ophthalmology Drugs Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Ophthalmology Drugs Market Size (2014-2019)
9.2 Ophthalmology Drugs Key Players in Southeast Asia
9.3 Southeast Asia Ophthalmology Drugs Market Size by Type
9.4 Southeast Asia Ophthalmology Drugs Market Size by Application

10 India
10.1 India Ophthalmology Drugs Market Size (2014-2019)
10.2 Ophthalmology Drugs Key Players in India
10.3 India Ophthalmology Drugs Market Size by Type
10.4 India Ophthalmology Drugs Market Size by Application

11 Central & South America
11.1 Central & South America Ophthalmology Drugs Market Size (2014-2019)
11.2 Ophthalmology Drugs Key Players in Central & South America
11.3 Central & South America Ophthalmology Drugs Market Size by Type
11.4 Central & South America Ophthalmology Drugs Market Size by Application

12 International Players Profiles
12.1 Novartis
12.1.1 Novartis Company Details
12.1.2 Company Description and Business Overview
12.1.3 Ophthalmology Drugs Introduction
12.1.4 Novartis Revenue in Ophthalmology Drugs Business (2014-2019)
12.1.5 Novartis Recent Development
12.2 Regeneron
12.2.1 Regeneron Company Details
12.2.2 Company Description and Business Overview
12.2.3 Ophthalmology Drugs Introduction
12.2.4 Regeneron Revenue in Ophthalmology Drugs Business (2014-2019)
12.2.5 Regeneron Recent Development
12.3 Roche
12.3.1 Roche Company Details
12.3.2 Company Description and Business Overview
12.3.3 Ophthalmology Drugs Introduction
12.3.4 Roche Revenue in Ophthalmology Drugs Business (2014-2019)
12.3.5 Roche Recent Development
12.4 Bayer
12.4.1 Bayer Company Details
12.4.2 Company Description and Business Overview
12.4.3 Ophthalmology Drugs Introduction
12.4.4 Bayer Revenue in Ophthalmology Drugs Business (2014-2019)
12.4.5 Bayer Recent Development
12.5 Allergan
12.5.1 Allergan Company Details
12.5.2 Company Description and Business Overview
12.5.3 Ophthalmology Drugs Introduction
12.5.4 Allergan Revenue in Ophthalmology Drugs Business (2014-2019)
12.5.5 Allergan Recent Development
12.6 Shire
12.6.1 Shire Company Details
12.6.2 Company Description and Business Overview
12.6.3 Ophthalmology Drugs Introduction
12.6.4 Shire Revenue in Ophthalmology Drugs Business (2014-2019)
12.6.5 Shire Recent Development
12.7 Mallinckrodt
12.7.1 Mallinckrodt Company Details
12.7.2 Company Description and Business Overview
12.7.3 Ophthalmology Drugs Introduction
12.7.4 Mallinckrodt Revenue in Ophthalmology Drugs Business (2014-2019)
12.7.5 Mallinckrodt Recent Development
12.8 Santen Pharmaceutical
12.8.1 Santen Pharmaceutical Company Details
12.8.2 Company Description and Business Overview
12.8.3 Ophthalmology Drugs Introduction
12.8.4 Santen Pharmaceutical Revenue in Ophthalmology Drugs Business (2014-2019)
12.8.5 Santen Pharmaceutical Recent Development
12.9 Aerie
12.9.1 Aerie Company Details
12.9.2 Company Description and Business Overview
12.9.3 Ophthalmology Drugs Introduction
12.9.4 Aerie Revenue in Ophthalmology Drugs Business (2014-2019)
12.9.5 Aerie Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Table

List of Tables and Figures

Table Ophthalmology Drugs Key Market Segments
Table Key Players Ophthalmology Drugs Covered
Table Global Ophthalmology Drugs Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Ophthalmology Drugs Market Size Market Share by Type 2014-2025
Figure Lucentis (Ranibizumab) Figures
Table Key Players of Lucentis (Ranibizumab)
Figure Eylea (Aflibercept) Figures
Table Key Players of Eylea (Aflibercept)
Figure Avastin (Bevacizumab) Figures
Table Key Players of Avastin (Bevacizumab)
Figure Restasis (Cyclosporine) Figures
Table Key Players of Restasis (Cyclosporine)
Figure Alphagan (Brimonidine Tartrate) Figures
Table Key Players of Alphagan (Brimonidine Tartrate)
Figure Lumigan (Bimatoprost) Figures
Table Key Players of Lumigan (Bimatoprost)
Figure Xalatan (Latanoprost) Figures
Table Key Players of Xalatan (Latanoprost)
Figure Conclusion Figures
Table Key Players of Conclusion
Table Global Ophthalmology Drugs Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Pharmacies Case Studies
Figure Retail Pharmacies Case Studies
Figure Drug Stores Case Studies
Figure Online Sales Case Studies
Figure Ophthalmology Drugs Report Years Considered
Table Global Ophthalmology Drugs Market Size 2014-2025 (Million US$)
Figure Global Ophthalmology Drugs Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Ophthalmology Drugs Market Size by Regions 2014-2025 (Million US$)
Table Global Ophthalmology Drugs Market Size by Regions 2014-2019 (Million US$)
Table Global Ophthalmology Drugs Market Share by Regions 2014-2019
Figure Global Ophthalmology Drugs Market Share by Regions 2014-2019
Figure Global Ophthalmology Drugs Market Share by Regions 2019
Table Market Top Trends
Table Global Ophthalmology Drugs Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Ophthalmology Drugs Market Share by Manufacturers (2014-2019)
Figure Global Ophthalmology Drugs Market Share by Manufacturers in 2018
Table Global Ophthalmology Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Ophthalmology Drugs Product/Solution/Service
Table Date of Enter into Ophthalmology Drugs Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Ophthalmology Drugs Market Size by Type (2014-2019) (Million US$)
Table Global Ophthalmology Drugs Market Size Share by Type (2014-2019)
Figure Global Ophthalmology Drugs Market Size Market Share by Type (2014-2019)
Table Global Ophthalmology Drugs Market Size by Application (2014-2019) (Million US$)
Table Global Ophthalmology Drugs Market Size Share by Application (2014-2019)
Figure Global Ophthalmology Drugs Market Size Market Share by Application (2014-2019)
Figure Global Ophthalmology Drugs Revenue Market Share by Application in 2018
Figure United States Ophthalmology Drugs Market Size 2014-2019 (Million US$)
Table United States Key Players Ophthalmology Drugs Revenue (2018-2019) (Million US$)
Table United States Key Players Ophthalmology Drugs Market Share (2018-2019)
Table United States Ophthalmology Drugs Market Size by Type (2014-2019) (Million US$)
Table United States Ophthalmology Drugs Market Share by Type (2014-2019)
Table United States Ophthalmology Drugs Market Size by Application (2014-2019) (Million US$)
Table United States Ophthalmology Drugs Market Share by Application (2014-2019)
Figure Europe Ophthalmology Drugs Market Size 2014-2019 (Million US$)
Table Europe Key Players Ophthalmology Drugs Revenue (2018-2019) (Million US$)
Table Europe Key Players Ophthalmology Drugs Market Share (2018-2019)
Table Europe Ophthalmology Drugs Market Size by Type (2014-2019) (Million US$)
Table Europe Ophthalmology Drugs Market Share by Type (2014-2019)
Table Europe Ophthalmology Drugs Market Size by Application (2014-2019) (Million US$)
Table Europe Ophthalmology Drugs Market Share by Application (2014-2019)
Figure China Ophthalmology Drugs Market Size 2014-2019 (Million US$)
Table China Key Players Ophthalmology Drugs Revenue (2018-2019) (Million US$)
Table China Key Players Ophthalmology Drugs Market Share (2018-2019)
Table China Ophthalmology Drugs Market Size by Type (2014-20189) (Million US$)
Table China Ophthalmology Drugs Market Share by Type (2014-2019)
Table China Ophthalmology Drugs Market Size by Application (2014-2019) (Million US$)
Table China Ophthalmology Drugs Market Share by Application (2014-2019)
Figure Japan Ophthalmology Drugs Market Size 2014-2019 (Million US$)
Table Japan Key Players Ophthalmology Drugs Revenue (2018-2019) (Million US$)
Table Japan Key Players Ophthalmology Drugs Market Share (2018-2019)
Table Japan Ophthalmology Drugs Market Size by Type (2014-2019) (Million US$)
Table Japan Ophthalmology Drugs Market Share by Type (2014-2019)
Table Japan Ophthalmology Drugs Market Size by Application (2014-2019) (Million US$)
Table Japan Ophthalmology Drugs Market Share by Application (2014-2019)
Figure Southeast Asia Ophthalmology Drugs Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Ophthalmology Drugs Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Ophthalmology Drugs Market Share (2018-2019)
Table Southeast Asia Ophthalmology Drugs Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Ophthalmology Drugs Market Share by Type (2014-2019)
Table Southeast Asia Ophthalmology Drugs Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Ophthalmology Drugs Market Share by Application (2014-2019)
Figure India Ophthalmology Drugs Market Size 2014-2019 (Million US$)
Table India Key Players Ophthalmology Drugs Revenue (2018-2019) (Million US$)
Table India Key Players Ophthalmology Drugs Market Share (2018-2019)
Table India Ophthalmology Drugs Market Size by Type (2014-2019) (Million US$)
Table India Ophthalmology Drugs Market Share by Type (2014-2019)
Table India Ophthalmology Drugs Market Size by Application (2014-2019) (Million US$)
Table India Ophthalmology Drugs Market Share by Application (2014-2019)
Figure Central & South America Ophthalmology Drugs Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Ophthalmology Drugs Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Ophthalmology Drugs Market Share (2018-2019)
Table Central & South America Ophthalmology Drugs Market Size by Type (2014-2019) (Million US$)
Table Central & South America Ophthalmology Drugs Market Share by Type (2014-2019)
Table Central & South America Ophthalmology Drugs Market Size by Application (2014-2019) (Million US$)
Table Central & South America Ophthalmology Drugs Market Share by Application (2014-2019)
Table Novartis Company Details
Table Novartis Revenue in Ophthalmology Drugs Business (2014-2019) (Million US$)
Figure Novartis Revenue Growth Rate in Ophthalmology Drugs Business (2014-2019)
Table Novartis Recent Development
Table Regeneron Company Details
Table Regeneron Revenue in Ophthalmology Drugs Business (2014-2019)(Million US$)
Figure Regeneron Revenue Growth Rate in Ophthalmology Drugs Business (2014-2019)
Table Regeneron Recent Development
Table Roche Company Details
Table Roche Revenue in Ophthalmology Drugs Business (2014-2019)(Million US$)
Figure Roche Revenue Growth Rate in Ophthalmology Drugs Business (2014-2019)
Table Roche Recent Development
Table Bayer Company Details
Table Bayer Revenue in Ophthalmology Drugs Business (2014-2019)(Million US$)
Figure Bayer Revenue Growth Rate in Ophthalmology Drugs Business (2014-2019)
Table Bayer Recent Development
Table Allergan Company Details
Table Allergan Revenue in Ophthalmology Drugs Business (2014-2019)(Million US$)
Figure Allergan Revenue Growth Rate in Ophthalmology Drugs Business (2014-2019)
Table Allergan Recent Development
Table Shire Company Details
Table Shire Revenue in Ophthalmology Drugs Business (2014-2019)(Million US$)
Figure Shire Revenue Growth Rate in Ophthalmology Drugs Business (2014-2019)
Table Shire Recent Development
Table Mallinckrodt Company Details
Table Mallinckrodt Revenue in Ophthalmology Drugs Business (2014-2019)(Million US$)
Figure Mallinckrodt Revenue Growth Rate in Ophthalmology Drugs Business (2014-2019)
Table Mallinckrodt Recent Development
Table Santen Pharmaceutical Company Details
Table Santen Pharmaceutical Revenue in Ophthalmology Drugs Business (2014-2019)(Million US$)
Figure Santen Pharmaceutical Revenue Growth Rate in Ophthalmology Drugs Business (2014-2019)
Table Santen Pharmaceutical Recent Development
Table Aerie Company Details
Table Aerie Revenue in Ophthalmology Drugs Business (2014-2019)(Million US$)
Figure Aerie Revenue Growth Rate in Ophthalmology Drugs Business (2014-2019)
Table Aerie Recent Development
Table Global Ophthalmology Drugs Market Size by Regions (Million US$) 2019-2025
Figure Global Ophthalmology Drugs Market Size Share by Regions (2019-2025)
Figure Global Ophthalmology Drugs Market Size Share by Regions in 2025
Figure United States Ophthalmology Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Europe Ophthalmology Drugs Market Size Forecast (2019-2025)(Million USD)
Figure China Ophthalmology Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Japan Ophthalmology Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Ophthalmology Drugs Market Size Forecast (2019-2025)(Million USD)
Figure India Ophthalmology Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Ophthalmology Drugs Market Size Forecast (2019-2025)(Million USD)
Table Global Ophthalmology Drugs Market Size by Product (2019-2025) (Million US$)
Figure Global Ophthalmology Drugs Market Size by Product (2019-2025)
Figure Global Ophthalmology Drugs Market Size by Product in 2025
Table Global Ophthalmology Drugs Market Size by Application (2019-2025) (Million US$)
Figure Global Ophthalmology Drugs Market Size by Application (2019-2025)
Figure Global Ophthalmology Drugs Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *